Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
08/2003
08/13/2003CN1117573C Protein iron microelement complement agent and its producing method
08/13/2003CN1117572C Medicine powder for treating athlete's foot, smelly foot and sweaty foot
08/13/2003CN1117562C Compositions and method for controlling smoking
08/13/2003CN1117561C Compounded calcium preparation, preparing method and use thereof
08/13/2003CN1117559C Activated and concentrated liquid contg. minerals and race elements
08/12/2003US6605297 Accelerating uncoupled respiration and proton leak of the inner membrane of mitochondria which are induced by uncoupling proteins usingcoupled isomerized highly unsaturated fatty acids
08/12/2003US6605286 Delivery of biologically active polypeptides
08/12/2003US6605275 Growing in vitro human neonatal or fetal hematopoietic stem cells from umbilical cord or placental blood collected at birth, introducing into human patient effective amount of progeny stem cells for hematopoietic reconstitution
08/07/2003WO2003064666A1 Adenoviral vectors for modulating the cellular activities associated with pods
08/07/2003WO2003064658A1 Alpha 1,3 galactosyltransferase mutant pigs
08/07/2003WO2003064632A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
08/07/2003WO2003064607A2 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions
08/07/2003WO2003064601A2 Adult human olfactory stem cell
08/07/2003WO2003064444A1 Fractionation of phytosterol esters in oil
08/07/2003WO2003063915A1 Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
08/07/2003WO2003063902A2 Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitizers
08/07/2003WO2003063900A1 Process for the preparation of a nutrient formulation
08/07/2003WO2003063896A1 Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
08/07/2003WO2003063886A1 Helicobacter pylori adhesion inhibitor
08/07/2003WO2003063883A1 Mkrtachian embryonal antitumoral modulator, method for the production and use thereof
08/07/2003WO2003063786A2 Methods and composition for delivering nucleic acids and/or proteins to the respiratory system
08/07/2003WO2003063785A2 Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
08/07/2003WO2003063686A2 Bone repair material
08/07/2003WO2003063610A1 Oil including omega-3 fatty acids with therapeutic properties
08/07/2003WO2003063593A1 Methods for treating cancer by administering tumor-targetted bacteria and an immunomodulatory agent
08/07/2003WO2003020113A3 The use of low-power laser irradiation for enhanced vascularization of tissue and tissue-engineered construct transplants
08/07/2003WO2003018788B1 Improved nitroreductase enzymes
08/07/2003WO2002092825B1 Retroviral vectors for gene therapy
08/07/2003WO2002088334A9 Chimeric immunoreceptor useful in treating human cancers
08/07/2003WO2002064157A3 Localized myocardial injection method for treating ischemic myocardium
08/07/2003WO2002046386A3 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003WO2002030259A9 Disease prevention by reactivation of the thymus
08/07/2003WO2002000172A3 Methods for using tetanus toxin for benificial purposes in animals (mammals)
08/07/2003US20030150000 Biological models capable of exhibiting secondary disease manifestations and useful for developing therapeutic drugs, diagnostic products and therapeutic or diagnostic procedures, methods of using same, and cells, tissues and organs derived therefrom
08/07/2003US20030149011 Methods and reagents for extracorporeal immunomodulatory therapy
08/07/2003US20030148986 For therapy of atherosclerosis and other vascular diseases such as thrombosis, restenosis after angioplasty and/or stenting, and vein-graft disease after bypass surgery
08/07/2003US20030148948 Super-active porcine growth hormone releasing hormone analog
08/07/2003US20030148947 MIP as a research tool for identification, characterization and purification of molecules involved in cellular transport and osmotic regulation; agonists/antagonists; vision defects; anitinflammatory agents; nervous system and kidney disorders
08/07/2003US20030148515 Generating blood producing tissues from central nervous system pluripotent cells for repair, regeneration or augmentation of mammalian hematopoietic system; gene therapy; tissue engineering; blood disorders; anticarcinogenic agents
08/07/2003US20030148514 Human embryonic germ cell line and methods of use
08/07/2003US20030148513 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
08/07/2003US20030148512 Preparing culture of vascular system progenitor cells for tissue engineering and treatment of vascular disorders
08/07/2003US20030148511 Induction of immunity using inhibitors of granzymes
08/07/2003US20030148509 Retrovirus isolated from humans
08/07/2003US20030148456 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
08/07/2003US20030148451 Endothelial differntiation gene 6-like g protein coupled receptor
08/07/2003US20030148420 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003US20030148325 Infectious clones
08/07/2003US20030148262 Chimeric alphavirus replicon particles
08/07/2003US20030148256 Storage solution of sodium citrate, sodium biphosphate, sodium phosphate dibasic, adenine, and mannitol, and physiological pH
08/07/2003US20030147969 Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
08/07/2003US20030147923 Composition & corresponding method of using spores of bacillus subtilis to stimulate and/or enhance immune response in mammals
08/07/2003US20030147922 Vaccine against streptococcus pneumoniae capsular polysaccharides
08/07/2003US20030147910 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
08/07/2003US20030147907 Retroviral vectors
08/07/2003US20030147905 Administering an oligopeptide for immunotherapy
08/07/2003US20030147903 ABC transport polynucleotides, polypeptides and antibodies
08/07/2003US20030147896 A mixture of seven herbs, extract or chemically synthesized as anticancer agent: Tinospora cordifolia, Chlorphyton borivilianum, Curcuma longa, Asparagus racemosus, Hygrophila auriculata, Achyranthus aspera and Elephantopus scaber
08/07/2003US20030147883 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection
08/07/2003US20030147873 Cell culture prodcut for treating a behavioral or psychological disorders and brian disorders, brain transplant; stem cells
08/07/2003US20030147865 Cell therapy using immunoregulatory T-cells
08/07/2003US20030147861 Compounds and methods for the modulation of immune responses
08/07/2003US20030147860 A mixture of animal growth factors, hyaluronic acid, chitosan or chitosan derivatives for treating bone disorders or filling a bone defect
08/07/2003US20030147859 Administering to the recipient a dose of cultured cells from the donor, before the transplant surgery; administering antigenic determinant for treating autoimmune disease
08/07/2003US20030147858 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
08/07/2003US20030147857 Probiotic/prebiotic composition and delivery method
08/07/2003US20030147852 Toxin-phage bacteriocide antibiotic and uses thereof
08/07/2003CA2514518A1 Process for the preparation of a nutrient formulation
08/07/2003CA2474777A1 Adenoviral vectors for modulating the cellular activities associated with pods
08/07/2003CA2474620A1 Helicobacter pylori adhesion inhibitor
08/07/2003CA2474571A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
08/07/2003CA2473353A1 Adult human olfactory stem cell
08/07/2003CA2473250A1 Fractionation of phytosterol esters in oil
08/06/2003EP1333094A2 Human telomerase catalytic subunit
08/06/2003EP1332673A1 Method of controlling proliferation and differentiation of stem and progenitor cells
08/06/2003EP1332366A1 Methods for the treatment of cellular proliferative disorders
08/06/2003EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1331977A1 Blood centrifuge cup having a replaceable compartment for filter support
08/06/2003EP1331950A1 Methods and compositions for nucleic acid delivery
08/06/2003EP1331948A2 Pharmaceutical composition containing honey for the treatment of wounds
08/06/2003EP1331940A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
08/06/2003EP1331938A1 Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome
08/06/2003EP1276431A4 Method for expansion of epithelial stem cells
08/06/2003EP1083934B1 EGR-1 for the manufacture of a medicament for treating wounds
08/06/2003EP1015570A4 Fibrin microbeads and uses thereof
08/06/2003CN1434865A Regulation effect of conjugated frame transport protein ABC1
08/06/2003CN1434727A Anglogenesis and vascular permeability modulators and inhibitors
08/06/2003CN1434718A Activation and inhibition of immune system
08/06/2003CN1434716A Anti-adhesive agent in relation to pathogenic flora of skin
08/06/2003CN1434681A Method for maintaining on improving the synthesis of mucins
08/06/2003CN1434121A Fermentation production technology for olry bacterial powder containing gama-linolenic acid
08/06/2003CN1434119A Establishment and use of adult stem cell restitution hemopoiesis method of mesenchyme stem cell phynotype
08/06/2003CN1434115A Streptomycete albogriseus spnov
08/06/2003CN1433806A Medicated liquor for treating chronic osteonosus
08/06/2003CN1433805A Medicine for treating gastritis and preparation process thereof
08/06/2003CN1433787A Oral taken and external use medicine for antirheumatism and stopping numbness pain
08/06/2003CN1433779A Process for preparing snake venom hemostatic medicine
08/06/2003CN1433778A Powder medicine for treating otitis media and preparation method thereof
08/06/2003CN1433777A Cerium carried (Ôàó) rectorite anti-inflammatory and bacteriostatic medicine and preparation process thereof
08/06/2003CN1433769A Boping capsule preparation for treating cardiovascular and cevebrovascnlar disease and preparation process thereof
1 ... 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 ... 1259